Name: 2026 Neurotech Leaders Forum
Start: 2026-11-09
End: 2026-11-10
Location: South San Francisco

Overview

A Two-Day Investment and Management Conference for Neurotechnology Entrepreneurs and Executives

This two-day conference offers an exclusive forum for executives and entrepreneurs from the neurotechnology industry to interact with investors, technologists, and potential partners who are actively working to grow this market. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neuroscience industry and the investment community.

Sessions will cover a range of technologies and market segments in the neuro space, including neuromodulation, neuroprosthetics, neurodiagnostics, and neurorehabilitation. Attendees will hear from leading researchers and entrepreneurs developing clinically and commercially promising products such as deep-brain stimulation systems, stroke rehabilitation devices, implanted pain stimulators, brain-computer interfaces, and advanced brain sensing technologies.

The Summit covers new frontiers in the neurotechnology industry, including applications in bioelectronic medicine, neurosensing, noninvasive stimulation, and biomarkers. Both days feature presentations from several early-stage neurotechnology firms covering a range of product and technology areas.

Program

Monday, November 9

TIME	SESSION
7:30 am	Registration Open
7:30 am	Breakfast & Networking (Sponsorship Opportunity Available)
8:30 am	Opening Presentation: State of the Neurotech Industry 2026 James Cavuoto, Editor & Publisher, Neurotech Reports Presented by Neurotech Business Reports Editor, James Cavuoto, this session is designed to share key insights and observations on the state of the neurotechnology industry. Insights into the most significant industry events that occurred throughout 2026. Sharing the most exciting breakthroughs, partnerships, and outcomes of the year. What changes have we seen in the competitive landscape throughout the year? What are the most significant roadblocks, hurdles, and challenges that we are yet to overcome? Where do the opportunities lie for neurotechnology in 2027? What to expect from the Neurotech Leaders Forum this year.
9:15 am	Keynote Address to be Announced
10:00 am	Morning Refreshments & Networking (Sponsorship Opportunity Available)
10:30 am	Neurotechnology Entrepreneur Panel The first of our four entrepreneur panels, hear from three new and innovative neurotechnology companies as they share what they’re building, the problem they’re solving, and what next steps they are looking to take to scale, grow, and get into the hands of the patients. Now Accepting Applications \| Apply Here
11:15 am	PANEL DISCUSSION: The Neurotech Funding Outlook PANEL MODERATOR: Jeremy Koff, Senior Consulting Editor, Neurotech Reports Neurotechnology funding is entering a new phase, moving beyond a few headline deals into a broader, more durable market. This panel explores where capital is really flowing, what’s driving the shift, and what it means for both founders and investors. Which neurotech sub-sectors are investors most excited about right now, and which are struggling to find funding? What separates a company that raises easily from one that struggles? How are regulatory shifts (FDA, reimbursement pathways) shaping which companies are attracting capital? Beyond traditional VC, how should founders think about alternative capital? What evidence do investors need to see before pulling the trigger on investment and what stage companies are typically seeing larger funding rounds?
12:00 pm	Networking Luncheon (Sponsorship Opportunity Available)
1:30 pm	Neurotechnology Entrepreneur Panel The second of four entrepreneur panels, hear from three new and innovative neurotechnology companies as they share what they’re building, the problem they’re solving, and what next steps they are looking to take to scale, grow, and get into the hands of the patients. Now Accepting Applications \| Apply Here
2:15 pm	PANEL DISCUSSION: Decoding the Future \| AI-Driven Implanted Technology PANEL MODERATOR: Jojo Platt, Contributing Editor, Neurotech Reports AI is reshaping what’s possible in brain-computer interfaces, from foundational models that generalize across users to generative decoding that reconstructs speech and imagery from neural signals. However, key hurdles remain with questions around reliability, regulation, and ethics that come from reading the brain at scale. This panel explores where AI is truly advancing BCI and where caution is still warranted. What’s standing between lab-grade decoding accuracy and reliable, everyday BCI performance? What would a regulatory pathway look like for closed-loop systems that keep learning after deployment? Who owns neural data and how does its sensitivity differ from other personal data? Where are foundational and language models moving the needle on BCI decoding and what’s just hype? What ethical guardrails are needed as BCI’s move into neuroadaptive applications and mood sensing?
3:00 pm	Afternoon Refreshments & Networking (Sponsorship Opportunity Available)
3:30 pm	PANEL DISCUSSION: Neurotechnology Advancements within Women's Healthcare PANEL MODERATOR: Jojo Platt, Contributing Editor, Neurotech Reports Neurotechnology is opening new frontiers in women's health, from wearable neurostimulation for PMDD and perimenopausal mood shifts to brain-based diagnostics for conditions historically dismissed or misunderstood. This panel brings together founders and clinicians building tools that treat the nervous system as central to women's health, not an afterthought. How can brain-based tools like EEG, neuroimaging, and biomarker platforms help identify conditions such as PMDD, postpartum depression, and menopause-related cognitive changes that are routinely misdiagnosed or dismissed? What does it mean to treat mood and cognitive symptoms by targeting the brain's sensitivity to hormonal fluctuation, rather than suppressing hormones themselves? What does the path look like for taking neurostimulation and neurofeedback devices from clinical trials to at-home, wearable products women can access without a specialist and where are the biggest pitfalls? Why has women's health historically captured such a small share of both healthcare and neurotech investment, and what's driving renewed capital into this intersection now? How should the industry navigate FDA pathways and data privacy for neural data, and what will it take to ensure devices are validated across diverse populations rather than a narrow clinical trial demographic?
4:15 pm	PANEL DISCUSSION: From Bench to Bedside \| Closing the Adoption Gap PANEL MODERATOR: Jeremy Koff, Senior Consulting Editor, Neurotech Reports FDA clearance is a milestone, yet not the finish line. Established neurotech therapies like DBS and VNS still only reach a small fraction of their addressable patient populations, a gap driven less by clinical evidence and more by clinical workflow, reimbursement timelines and physician awareness. This panel will unpack what really happens between a device clearing regulatory hurdles and becoming the standard of care. A discussion into what actually slows adoption after regulatory clearance How do health systems evaluate and prioritize a new neurotech offering internally? What does it take to build physician champions and durable referral pathways for new healthcare technology? What does a successful implementation look like to a hospital administrator versus a device maker?
5:00 pm	Cocktail Reception & Networking
6:30 pm	Close of Day

Tuesday, November 10

TIME	SESSION
8:00 am	Registration Open
8:00 am	Breakfast & Networking (Sponsorship Opportunity Available)
8:30 am	Keynote Address to be Announced
9:15 am	PANEL DISCUSSION: Bioelectronic Medicine Comes of Age PANEL MODERATOR: James Cavuoto, Editor & Publisher, Neurotech Reports Bioelectronic medicine is expanding well past pain management. Vagus and peripheral nerve stimulation have shown signals in inflammation, metabolic disease, and autonomic disorders. This panel explores how peripheral nerve stimulation is carving out its place alongside well-established therapies, where the next wave of indications is heading, and how to scale these therapies. How is peripheral nerve stimulation competing with, and complementing, spinal cord stimulation? What will it take for bioelectronic therapies to move beyond pain and into inflammation, metabolic, and autonomic disorders? What manufacturing and miniaturization challenges are unique to peripheral nerve stimulation? What are strategics looking for when scouting bioelectronic medicine acquisitions?
10:00 am	Morning Refreshments & Networking (Sponsorship Opportunity Available)
10:30 am	PANEL DISCUSSION: Wear it Well \| The Noninvasive Neurotech Boom PANEL MODERATOR: Jeremy Koff, Senior Consulting Editor, Neurotech Reports Wearable EEG, at-home neuromodulation, and consumer BCI are moving fast, with some earning FDA clearance for real clinical indications while others have settled squarely in the wellness space with far lighter evidence requirements. As the line between 'medical device' and 'consumer gadget' gets blurry, this panel will unpack how companies are drawing that line, what claims can and can’t be made without clinical data, and how DTC and clinical channels are playing out in the fast-growing market. How do we draw the line between consumer and medical-grade positioning What evidence standards do noninvasive neuromodulation claims need to clear and how does this effect adoption? How do DTC and clinical channel strategies converge and differ, and can a company credibly do both?
11:15 am	Neurotechnology Entrepreneur Panel The third of our four entrepreneur panels, hear from three new and innovative neurotechnology companies as they share what they’re building, the problem they’re solving, and what next steps they are looking to take to scale, grow, and get into the hands of the patients. Now Accepting Applications \| Apply Here
12:00 pm	Networking Luncheon
1:30 pm	Neurotechnology Entrepreneur Panel The final of four entrepreneur panels, hear from three new and innovative neurotechnology companies as they share what they’re building, the problem they’re solving, and what next steps they are looking to take to scale, grow, and get into the hands of the patients. Now Accepting Applications \| Apply Here
2:15 pm	PANEL DISCUSSION: Paying the Price \| Regulation, Reimbursement & Reality PANEL MODERATOR: Jojo Platt, Contributing Editor, Neurotech Reports Neurotech companies are navigating a moving landscape with rules for submissions, coverage, coding, and regulation shifting in real time. This panel brings together regulatory and reimbursement experts to help attendees understand what’s actually changed, what it means for getting a first-in-class device covered, and how to prepare for the next shift before it lands. What’s actually changed at FDA and CMS leadership, and how does it effect neurotech submissions and coverage decisions? What does it really take to secure a novel CPT code or coverage determination for a first-in-class device? How are payors evaluating neurotech reimbursement requests differently than a traditional device? How can companies prepare for policy shifts proactively?
3:00 pm	Afternoon Refreshments & Networking (Sponsorship Opportunity Available)
3:30 pm	PANEL DISCUSSION: What's Next? \| The Bet's Shaping Neurotech's Future PANEL MODERATOR: James Cavuoto, Editor & Publisher, Neurotech Reports Where are the big medtech and strategics placing their R&D bets for the next five years? What materials sciences and miniaturization breakthroughs are enabling the next generation of implants? What are the biggest challenges facing the neurotech industry, and how can we hope to overcome these?
4:15 pm	Closing Fireside Chat to be Announced
5:00 pm	Cocktail Reception & Networking (Sponsorship Opportunity Available)
6:30 pm	Close of Forum

Register

Reserve your spot for the 2026 Neurotech Leaders Forum.

Location

South San Francisco CA